Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-07-001301
Filing Date
2007-07-17
Accepted
2007-07-17 10:15:25
Documents
2
Group Members
DANIEL S. LOEBJASON ARYEHTHIRD POINT OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 p3835651b.txt SC 13D/A 24171
3 THIRD POINT LETTER DATED 7/16/07 p3835651c.txt EX-99.1 27538
  Complete submission text file 0000899140-07-001301.txt   53994
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43256 | Film No.: 07983065
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

EIN.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A